Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Cyprotex Launch Updated Drug-Drug Interaction Regulatory Guidance

Published: Friday, August 17, 2012
Last Updated: Friday, August 17, 2012
Bookmark and Share
Booklet to reflect the new FDA and EMA guidelines.

Cyprotex PLC have today launched an update of their popular Drug-Drug Interaction Regulatory Guidance booklet.

Important new regulatory guidelines for drug-drug interaction (DDI) studies have been released this year. Initially, draft FDA guidance for drug interactions studies were released for comment in February. In June, the European Medicines Agency (EMA) adopted a new guideline on the investigation of drug interactions and this is due to come into effect as of January 2013.

By popular request from our customers, Cyprotex have constructed an easy-to-follow pocket-sized handbook entitled ‘DDI Regulatory Guidance – An easy to follow guide’ which summarises key information from the latest drug interaction guidance documents. It offers a side-by-side comparison of the recommendations from both the FDA and EMA regulatory authorities. The handbook assists in the design and planning of in vitro DDI studies and provides concise information on how the data are used to guide clinical DDI studies.

Commenting on the launch of the handbook, Dr. Anthony Baxter, Chief Executive Officer of Cyprotex, said: “Our DDI handbook provides a valuable resource for scientists who can now access the key information from the regulatory authorities in an easy-to-read format. The handbook also acts as an educational tool for new scientists in the field who are unfamiliar with these guidelines. We have had an overwhelming response to the revised handbook, with over 500 potential customers already pre-ordering the updated version, which will be distributed later this week.”

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Cyprotex Appoints Dr Rob Elsby as Leader of Drug Transporter Team
Cyprotex PLC has appointed Dr Rob Elsby as Leader of its Drug Transporter Team.
Wednesday, March 18, 2015
Cyprotex Acquires CeeTox
Auquistion broadens toxicological assay and screening capabilities to the cosmetic and personal care industry.
Thursday, January 02, 2014
Cyprotex Announces a Collaborative Research Agreement with Pfizer
The deal extends over an eighteen month period and is split into two stages with the second stage being dependent on certain milestones being achieved.
Friday, November 02, 2012
Sygnature Discovery and Cyprotex Extend Successful Strategic Alliance
The companies have announced they have entered into an extension of their highly successful partnership for a further 2 years.
Monday, December 19, 2011
Cyprotex Extends Cloe® Screen Mechanism-Based Inhibition Service to Include 4 Additional Cytochrome P450 Isoforms
New assays compliment the CYP3A4 isoform assay which was launched last year.
Friday, March 30, 2007
Scientific News
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Fighting Cancer with Immune Response
New treatment elicits two-pronged immune response that destroys tumors in mice.
Nanoparticles Offer Promising Platform for Flavivirus Treatment
New nanoparticle effectively vaccinated mice against one dengue strain and could be created to target all four.
First Entirely 3D-printed Organ-on-a-Chip with Integrated Sensors
New approach to manufacturing may allow researchers to rapidly design organs-on-chips that match the properties of a specific disease or individual patient's cells.
Study Finds Key Regulator in Pulmonary Fibrosis
Researchers identify an enzyme that could open the way to therpies for chronic fatal lung disease.
Signaling Pathway Could Be Key to Improved Osteoporosis Treatment
Inhibition of SIK2 enzyme both stimulates bone formation and reduces bone breakdown in animal model.
Ovarian Cancer Insight
Study showed tumours release cytokines to attract macrophages, which secrete growth factors that in turn promote tumour growth.
Substance Can Potentially Postpone Aging
Researchers bridge the gap between two main aging theories - repairs to the DNA and poor functioning mitochondria.
Untangling Cause Of Memory Loss In Neurodegenerative Diseases
NIH-funded mouse study identifies a possible therapeutic target for a family of disorders.
New Model for Understanding Human Myeloma
Researchers develop mouse model where mice carry six human genes involved in human tumour growth.

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos